Single cell RNA sequencing reveals endothelial cell killing and resolution pathways in experimental malaria-associated acute respiratory distress syndrome

PLoS Pathog. 2024 Jan 18;20(1):e1011929. doi: 10.1371/journal.ppat.1011929. eCollection 2024 Jan.

Abstract

Plasmodium parasites cause malaria, a global health disease that is responsible for more than 200 million clinical cases and 600 000 deaths each year. Most deaths are caused by various complications, including malaria-associated acute respiratory distress syndrome (MA-ARDS). Despite the very rapid and efficient killing of parasites with antimalarial drugs, 15% of patients with complicated malaria succumb. This stresses the importance of investigating resolution mechanisms that are involved in the recovery from these complications once the parasite is killed. To study the resolution of MA-ARDS, P. berghei NK65-infected C57BL/6 mice were treated with antimalarial drugs after onset of symptoms, resulting in 80% survival. Micro-computed tomography revealed alterations of the lungs upon infection, with an increase in total and non-aerated lung volume due to edema. Whole body plethysmography confirmed a drastically altered lung ventilation, which was restored during resolution. Single-cell RNA sequencing indicated an increased inflammatory state in the lungs upon infection, which was accompanied by a drastic decrease in endothelial cells, consistent with CD8+ T cell-mediated killing. During resolution, anti-inflammatory pathways were upregulated and proliferation of endothelial cells was observed. MultiNicheNet interactome analysis identified important changes in the ligand-receptor interactions during disease resolution that warrant further exploration in order to develop new therapeutic strategies. In conclusion, our study provides insights in pro-resolving pathways that limit inflammation and promote endothelial cell proliferation in experimental MA-ARDS. This information may be useful for the design of adjunctive treatments to enhance resolution after Plasmodium parasite killing by antimalarial drugs.

MeSH terms

  • Animals
  • Antimalarials* / pharmacology
  • Antimalarials* / therapeutic use
  • Endothelial Cells / metabolism
  • Humans
  • Malaria* / parasitology
  • Mice
  • Mice, Inbred C57BL
  • Plasmodium berghei
  • Respiratory Distress Syndrome* / etiology
  • Respiratory Distress Syndrome* / metabolism
  • Sequence Analysis, RNA
  • X-Ray Microtomography / adverse effects

Substances

  • Antimalarials

Grants and funding

This study was supported by Research Foundation-Flanders (F.W.O.- Vlaanderen, project G0C9720N and G066723N) and the Research Fund of the KU Leuven (C1 project C14/23/143). EP is a recipient of the L’Oréal-Unesco Women for Sciences and F.W.O.-Vlaanderen PhD fellowship, HP is a recipient of an aspirant PhD fellowship of the F.W.O.-Vlaanderen and LV is a recipient of a junior Postdoc fellowship of the F.W.O.-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.